Diabetes

Show filters
Filter search results Hide filters

Public health

Treatments, Procedures and Devices

Guidance type

Publication status

Date

From
To
 
Guidance formats Query

Patient

The summary of the key recommendations in the guidance written for patients, carers and those with little medical knowledge and may be used in local patient information leaflets.

Quick Reference Guide

The quick reference guide presents recommendations for health professionals

NICE Guideline

The published NICE clinical guideline, contains the recommendations for health professionals and NHS bodies.

Full Guideline

The published full clinical guideline for specialists with background, evidence, recommendations and methods used.

  • Technology appraisalsDiabetic macular oedema - fluocinolone acetonide intravitreal implant (TA271) (replaced by TA301)

    The summary of the published technology appraisal on Diabetic macular oedema - fluocinolone acetonide intravitreal implant. It links to the published guidance and key documents.

    View the summary and implementation tools 23 January 2013
  • Technology appraisalsDiabetic retinopathy - ruboxistaurin [ID382]

    The summary of the suspended technology appraisal on Diabetic retinopathy - ruboxistaurin [ID382]. It links to the suspended guidance and key documents.

  • Technology appraisalsDiabetes - buccal insulin [ID311]

    The summary of the in development technology appraisal on Diabetes - buccal insulin [ID311]. It links to the key documents, details of NICE staff and external stakeholders involved in developing NICE guidance.

  • Technology appraisalsMacular oedema (diabetic) - pegaptanib sodium [ID452]

    The summary of the suspended technology appraisal on Macular oedema (diabetic) - pegaptanib sodium [ID452]. It links to the suspended guidance and key documents.

  • Clinical guidelinesDiabetes in pregnancy

    The summary of the in development clinical guideline on Diabetes in pregnancy. It links to the key documents, details of NICE staff and external stakeholders involved in developing NICE guidance.

  • Clinical guidelinesDiabetes in children and young people

    The summary of the in development clinical guideline on Diabetes in children and young people. It links to the key documents, details of NICE staff and external stakeholders involved in developing NICE guidance.

  • Clinical guidelinesType 2 diabetes

    The summary of the in development clinical guideline on Type 2 diabetes. It links to the key documents, details of NICE staff and external stakeholders involved in developing NICE guidance.

  • Clinical guidelinesDiabetic foot problems

    The summary of the in development clinical guideline on Diabetic foot problems. It links to the key documents, details of NICE staff and external stakeholders involved in developing NICE guidance.

  • Technology appraisalsDiabetes (type 2) - canagliflozin [ID554]

    The summary of the in development technology appraisal on Diabetes (type 2) - canagliflozin [ID554]. It links to the key documents, details of NICE staff and external stakeholders involved in developing NICE guidance.

  • Technology appraisalsDiabetes (type 2) - empagliflozin [ID641]

    The summary of the in development technology appraisal on Diabetes (type 2) - empagliflozin [ID641]. It links to the key documents, details of NICE staff and external stakeholders involved in developing NICE guidance.

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.